23andMe has sold the rights to develop a drug based on its users’ DNA

Andy · Jan 13, 2020

DNA testing company 23andMe has sold the rights to a new drug that it has developed using its customers’ data. It is the first time the company has signed a deal to license a drug it developed.

The deal for the drug, which is being investigated as a potential treatment for inflammatory diseases, is with Spanish pharmaceutical company Almirall.

“This is a seminal moment for 23andMe,” Emily Drabant Conley, 23AndMe’s vice-president of business development told Bloomberg. “We’ve now gone from database to discovery to developing a drug.”
Click to expand...

https://www.newscientist.com/articl...hts-to-develop-a-drug-based-on-its-users-dna/

Log in or Sign up

23andMe has sold the rights to develop a drug based on its users’ DNA

Andy Committee Member

Share This Page

Log in or Sign up

23andMe has sold the rights to develop a drug based on its users’ DNA

Andy Committee Member

Share This Page

Useful Searches